Net profit of Bal Pharma rose 9.47% to Rs 1.04 crore in the quarter ended September 2024 as against Rs 0.95 crore during the previous quarter ended September 2023. Sales declined 20.37% to Rs 73.69 crore in the quarter ended September 2024 as against Rs 92.54 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales73.6992.54 -20 OPM %10.448.32 - PBDT3.844.02 -4 PBT1.361.60 -15 NP1.040.95 9 Powered by Capital Market - Live News

Bal Pharma will hold a meeting of the Board of Directors of the Company on 9 September 2024.Powered by Capital Market - Live News

Bal Pharma announced that the Annual General Meeting (AGM) of the company will be held on 25 September 2024.Powered by Capital Market - Live News

Net profit of Bal Pharma rose 225.00% to Rs 0.26 crore in the quarter ended June 2024 as against Rs 0.08 crore during the previous quarter ended June 2023. Sales rose 5.64% to Rs 74.36 crore in the quarter ended June 2024 as against Rs 70.39 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales74.3670.39 6 OPM %8.699.15 - PBDT3.052.96 3 PBT0.620.43 44 NP0.260.08 225 Powered by Capital Market - Live News

Bal Pharma will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live News